Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity

Nature Immunology

Volumn 14, Issue 8, 2013, Pages 793-803

  Li, Jianhua ^a   Liu, Kuancheng ^a   Liu, Yang ^a   Xu, Yan ^a   Zhang, Fei ^a   Yang, Huijuan ^a   Liu, Jiangxia ^a   Pan, Tingting ^a   Chen, Jieliang ^a   Wu, Min ^a   Zhou, Xiaohui ^a   Yuan, Zhenghong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; MESSENGER RNA; STAT1 PROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELL COMMUNICATION; CELL TRANSPORT; CONTROLLED STUDY; EXOSOME; GENE SILENCING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LIVER CELL; LIVER NONPARENCHYMAL CELL; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS REPLICATION; VIRUS RESISTANCE;

ANIMALS; EXOSOMES; HEP G2 CELLS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNOBLOTTING; INTERFERON-ALPHA; LIVER; MICE; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 84880797948     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2647     Document Type: Article

References (52)

1. Borden, E.C. et al. Interferons at age 50: Past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6, 975-990 (2007).
2. Chevaliez, S. & Pawlotsky, J.M. Interferons and their use in persistent viral infections. Handb. Exp. Pharmacol. 189, 203-241 (2009).
3. Randall, R.E. & Goodbourn, S. Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89, 1-47 (2008).
4. Blalock, J.E. & Baron, S. Interferon-induced transfer of viral resistance between animal cells. Nature 269, 422-425 (1977).
5. Théry, C., Ostrowski, M. & Segura, E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9, 581-593 (2009).
6. Mittelbrunn, M. & Sanchez-Madrid, F. Intercellular communication: Diverse structures for exchange of genetic information. Nat. Rev. Mol. Cell Biol. 13, 328-335 (2012).
7. Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659 (2007).
8. Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476 (2008).
9. Mittelbrunn, M. et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2, 282 (2011).
10. Montecalvo, A. et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119, 756-766 (2012).
11. Meckes, D.G. Jr. et al. Human tumor virus utilizes exosomes for intercellular communication. Proc. Natl. Acad. Sci. USA 107, 20370-20375 (2010).
12. Pegtel, D.M. et al. Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. USA 107, 6328-6333 (2010).
13. Mozes, L.W. Lack of interferon-induced transfer of viral resistance against murine leukemia virus or poliovirus in cocultivated cells. Virology 116, 359-362 (1982).
14. Seeger, C. & Mason, W.S. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64, 51-68 (2000).
15. Shepard, C.W., Simard, E.P., Finelli, L., Fiore, A.E. & Bell, B.P. Hepatitis B virus infection: Epidemiology and vaccination. Epidemiol. Rev. 28, 112-125 (2006).
16. Kwon, H. & Lok, A.S. Hepatitis B therapy. Nat. Rev. Gastroenterol. Hepatol. 8, 275-284 (2011).
17. Li, J. et al. Inhibition of hepatitis B virus replication by MyD88 involves accelerated degradation of pregenomic RNA and nuclear retention of pre-S/S RNAs. J. Virol. 84, 6387-6399 (2010).
18. Hiraga, N. et al. Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice. J. Hepatol. 51, 1046-1054 (2009).
19. Lutgehetmann, M. et al. Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice. Gastroenterology 140, 2074-2083 (2011).
20. Chen, J. et al. Hepatitis B virus polymerase impairs interferon-(-induced STA T activation through inhibition of importin-(5 and protein kinase C.-d. Hepatology 57, 470-482 (2013).
21. Gao, B., Jeong, W.I. & Tian, Z. Liver: An organ with predominant innate immunity. Hepatology 47, 729-736 (2008).
22. Ishibashi, H., Nakamura, M., Komori, A., Migita, K. & Shimoda, S. Liver architecture, cell function, and disease. Semin. Immunopathol. 31, 399-409 (2009).
23. Wu, M. et al. Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1. J. Gen. Virol. 88, 3260-3269 (2007).
24. Yang, P.L., Althage, A., Chung, J. & Chisari, F.V. Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 99, 13825-13830 (2002).
25. Ke, B. et al. Adoptive transfer of ex vivo HO-1 modified bone marrow-derived macrophages prevents liver ischemia and reperfusion injury. Mol. Ther. 18, 1019-1025 (2010).
26. Trajkovic, K. et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244-1247 (2008).
27. Kosaka, N. et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285, 17442-17452 (2010).
28. Dreux, M. et al. Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12, 558-570 (2012).
29. Bianco, F. et al. Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J. 28, 1043-1054 (2009).
30. Zhang, J., Reedy, M.C., Hannun, Y.A. & Obeid, L.M. Inhibition of caspases inhibits the release of apoptotic bodies: Bcl-2 inhibits the initiation of formation of apoptotic bodies in chemotherapeutic agent-induced apoptosis. J. Cell Biol. 145, 99-108 (1999).
31. Ostrowski, M. et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol 12, 19-30 (2010).
32. Thery, C., Amigorena, S., Raposo, G. & Clayton, A. in Current Protocols Cell Biology Ch 3, Unit 3, 22 (John Wiley & Sons, 2006).
33. Meckes, D.G. Jr. & Raab-Traub, N. Microvesicles and viral infection. J. Virol. 85, 12844-12854 (2011).
34. Turelli, P., Mangeat, B., Jost, S., Vianin, S. & Trono, D. Inhibition of hepatitis B virus replication by APOBEC3G. Science 303, 1829 (2004).
35. Park, I.H., Baek, K.W., Cho, E.Y. & Ahn, B.Y. PKR-dependent mechanisms of interferon-α for inhibiting hepatitis B virus replication. Mol. Cells 32, 167-172 (2011).
36. Keller, S. et al. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett. 278, 73-81 (2009).
37. Weiss, S.R. & Navas-Martin, S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol. Biol. Rev. 69, 635-664 (2005).
38. DuPage, M., Dooley, A.L. & Jacks, T. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat. Protoc. 4, 1064-1072 (2009).
39. Takahashi, K. et al. Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc. Natl. Acad. Sci. USA 107, 7431-7436 (2010).
40. Record, M., Subra, C., Silvente-Poirot, S. & Poirot, M. Exosomes as intercellular signalosomes and pharmacological effectors. Biochem. Pharmacol. 81, 1171-1182 (2011).
41. Gibbings, D.J., Ciaudo, C., Erhardt, M. & Voinnet, O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat. Cell Biol. 11, 1143-1149 (2009).
42. Khatua, A.K., Taylor, H.E., Hildreth, J.E. & Popik, W. Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells. J. Virol. 83, 512-521 (2009).
43. Chang, J., Block, T.M. & Guo, J.T. The innate immune response to hepatitis B virus infection: Implications for pathogenesis and therapy. Antiviral Res. 96, 405-413 (2012).
44. Mao, R. et al. Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells. J. Virol. 85, 1048-1057 (2011).
45. Xi, W. et al. Roles of TIPE2 in hepatitis B virus-induced hepatic inflammation in humans and mice. Mol. Immunol. 48, 1203-1208 (2011).
46. Diamond, M.S. & Farzan, M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 13, 46-57 (2013).
47. Pinkert, C.A., Ornitz, D.M., Brinster, R.L. & Palmiter, R.D. An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. Genes Dev. 1, 268-276 (1987).
48. Zhang, D.E., Hetherington, C.J., Chen, H.M. & Tenen, D.G. The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol. Cell. Biol. 14, 373-381 (1994).
49. Fadel, B.M., Boutet, S.C. & Quertermous, T. Octamer-dependent in vivo expression of the endothelial cell-specific TIE2 gene. J. Biol. Chem. 274, 20376-20383 (1999).
50. Auwerx, J. The Human leukemia-cell line, Thp-1-a multifaceted model for the study of monocyte-macrophage differentiation. Experientia 47, 22-31 (1991).
51. Köck, J. & Blum, H.E. Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H. J. Gen. Virol. 89, 1184-1191 (2008).
52. Liu, W. et al. Sample preparation method for isolation of single-cell types from mouse liver for proteomic studies. Proteomics 11, 3556-3564 (2011). Diseases